Oramed Pharmaceuticals (ORMP) Debt Ratio (2011 - 2024)

Oramed Pharmaceuticals' (ORMP) quarterly Debt Ratio came in at 0.16 in Q1 2024, down 31.99% on a QoQ basis from 0.23 in Q4 2023.

Oramed Pharmaceuticals (ORMP) Debt Ratio (2011 - 2024) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 11 years of Debt Ratio data on file, last reported at 0.16 in Q1 2024.

Quarterly Debt Ratio changed N/A year-over-year to 0.16 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.16 (changed N/A YoY) and the FY2023 annual result came in at 0.23, changed N/A from the prior year.
Debt Ratio slipped to 0.16 in Q1 2024, from 0.23 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.33 in Q3 2023 to a low of 0.0 in Q2 2021.
A 4-year average of 0.08 and a median of 0.0 in 2020 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2020 — Debt Ratio gained 9.39% — and 2021, when it slumped 33.48%.
Tracing ORMP's Debt Ratio over 4 years: stood at 0.0 in 2020, then tumbled by 68.26% to 0.0 in 2021, then soared by 31999.37% to 0.23 in 2023, then tumbled by 31.99% to 0.16 in 2024.
The last three Debt Ratio figures came in at 0.16 (Q1 2024), 0.23 (Q4 2023), and 0.33 (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	138.93 Bn	131.08 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.11 Bn	78.11 Bn	3.93 Bn	0.05
3	Argenx Se	65.43 Bn	60.25 Bn	1.37 Bn	-
4	Moderna	56.09 Bn	50.96 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	-
7	BioNTech SE	27.68 Bn	9.29 Bn	668.28 Mn	0.03
8	Insmed	27.49 Bn	26.32 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	0.47
10	Oramed Pharmaceuticals	200.07 Mn	200.07 Mn	-	-

Download Data